Iradimed (IRMD) Competitors $48.30 -0.97 (-1.97%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IRMD vs. UTMD, PLSE, TELA, ICAD, APYX, ENOV, IRTC, SLNO, CNMD, and TNDMShould you be buying Iradimed stock or one of its competitors? The main competitors of Iradimed include Utah Medical Products (UTMD), Pulse Biosciences (PLSE), TELA Bio (TELA), iCAD (ICAD), Apyx Medical (APYX), Enovis (ENOV), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), CONMED (CNMD), and Tandem Diabetes Care (TNDM). Iradimed vs. Utah Medical Products Pulse Biosciences TELA Bio iCAD Apyx Medical Enovis iRhythm Technologies Soleno Therapeutics CONMED Tandem Diabetes Care Iradimed (NASDAQ:IRMD) and Utah Medical Products (NASDAQ:UTMD) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership. Do insiders and institutionals hold more shares of IRMD or UTMD? 92.3% of Iradimed shares are owned by institutional investors. Comparatively, 69.6% of Utah Medical Products shares are owned by institutional investors. 37.1% of Iradimed shares are owned by insiders. Comparatively, 6.6% of Utah Medical Products shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor IRMD or UTMD? Iradimed received 99 more outperform votes than Utah Medical Products when rated by MarketBeat users. Likewise, 64.78% of users gave Iradimed an outperform vote while only 61.45% of users gave Utah Medical Products an outperform vote. CompanyUnderperformOutperformIradimedOutperform Votes25264.78% Underperform Votes13735.22% Utah Medical ProductsOutperform Votes15361.45% Underperform Votes9638.55% Do analysts rate IRMD or UTMD? Iradimed presently has a consensus price target of $60.00, indicating a potential upside of 24.22%. Given Iradimed's higher possible upside, research analysts clearly believe Iradimed is more favorable than Utah Medical Products.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Iradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Utah Medical Products 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media refer more to IRMD or UTMD? In the previous week, Iradimed had 9 more articles in the media than Utah Medical Products. MarketBeat recorded 12 mentions for Iradimed and 3 mentions for Utah Medical Products. Utah Medical Products' average media sentiment score of 0.96 beat Iradimed's score of 0.54 indicating that Utah Medical Products is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iradimed 1 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Utah Medical Products 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, IRMD or UTMD? Iradimed has a beta of 0.79, meaning that its share price is 21% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.08, meaning that its share price is 92% less volatile than the S&P 500. Is IRMD or UTMD a better dividend stock? Iradimed pays an annual dividend of $0.60 per share and has a dividend yield of 1.2%. Utah Medical Products pays an annual dividend of $1.20 per share and has a dividend yield of 1.9%. Iradimed pays out 41.1% of its earnings in the form of a dividend. Utah Medical Products pays out 28.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Utah Medical Products is clearly the better dividend stock, given its higher yield and lower payout ratio. Is IRMD or UTMD more profitable? Utah Medical Products has a net margin of 34.62% compared to Iradimed's net margin of 26.83%. Iradimed's return on equity of 24.71% beat Utah Medical Products' return on equity.Company Net Margins Return on Equity Return on Assets Iradimed26.83% 24.71% 20.86% Utah Medical Products 34.62%12.04%11.42% Which has higher valuation & earnings, IRMD or UTMD? Iradimed has higher revenue and earnings than Utah Medical Products. Utah Medical Products is trading at a lower price-to-earnings ratio than Iradimed, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIradimed$69.48M8.81$17.19M$1.4633.08Utah Medical Products$50.22M4.44$16.64M$4.2715.01 SummaryIradimed beats Utah Medical Products on 14 of the 19 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Iradimed News Delivered to You Automatically Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRMD vs. The Competition Export to ExcelMetricIradimedSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$611.96M$4.41B$5.54B$8.53BDividend Yield1.13%42.37%5.13%4.14%P/E Ratio33.0838.74114.8115.14Price / Sales8.8165.081,495.55100.10Price / Cash37.1749.0939.6734.08Price / Book8.534.264.665.02Net Income$17.19M$11.52M$119.06M$225.46M7 Day Performance-4.15%1.06%0.80%0.37%1 Month Performance-2.56%0.92%5.65%3.57%1 Year Performance17.80%39.37%36.75%29.43% Iradimed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRMDIradimed4.8625 of 5 stars$48.30-2.0%$60.00+24.2%+17.6%$611.96M$69.48M33.08110Dividend AnnouncementNews CoverageUTMDUtah Medical Products3.9597 of 5 stars$63.38-1.0%N/A-19.1%$220.56M$50.22M14.84180Analyst UpgradeNews CoveragePLSEPulse Biosciences1.2205 of 5 stars$17.36-0.4%N/A+232.4%$1.06B$700,000.000.00140Earnings ReportNews CoverageTELATELA Bio3.285 of 5 stars$2.75-2.1%$10.00+263.6%-49.7%$67.95M$58.45M-1.60120Upcoming EarningsICADiCAD0.464 of 5 stars$1.89+1.6%N/A+37.9%$50.16M$17.32M-17.1867Short Interest ↑APYXApyx Medical4.5083 of 5 stars$1.21+3.4%$5.00+313.2%-49.1%$41.91M$52.35M-1.48270Upcoming EarningsENOVEnovis2.955 of 5 stars$41.62+0.8%$67.00+61.0%-5.8%$2.32B$1.71B-25.076,550Upcoming EarningsIRTCiRhythm Technologies3.0804 of 5 stars$73.11+0.9%$111.60+52.6%-4.9%$2.28B$492.68M-15.042,000Earnings ReportAnalyst ForecastNews CoverageSLNOSoleno Therapeutics4.3012 of 5 stars$55.06-1.2%$69.86+26.9%+132.7%$2.14BN/A-22.5730Upcoming EarningsCNMDCONMED4.8114 of 5 stars$68.24+4.6%$79.80+16.9%-28.7%$2.10B$1.24B16.214,000Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeTNDMTandem Diabetes Care4.5355 of 5 stars$31.70+1.1%$55.13+73.9%+79.8%$2.08B$747.72M-15.172,400Upcoming EarningsPositive News Related Companies and Tools Related Companies UTMD Competitors PLSE Competitors TELA Competitors ICAD Competitors APYX Competitors ENOV Competitors IRTC Competitors SLNO Competitors CNMD Competitors TNDM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRMD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
